selegiline has been researched along with Smoking Cessation in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barclay, E; Goyarzu, P; Magallanes, N; Malin, DH; Mathews, H; Mills, WR; Moon, WD; Negrete, AP; Stephens, B; Vela, AJ | 1 |
| Ameli, N; Fortmann, SP; Killen, JD; Lazzeroni, LC; Murphy, GM; Ryan, HS; Sarginson, JE; Schatzberg, AF | 1 |
| George, TP; Jatlow, PI; O'Malley, SS; Potenza, MN; Reutenauer, EL; Weinberger, AH | 1 |
| George, TP; McKee, SA; Weinberger, AH | 2 |
| Bryson, SW; Fong, D; Fortmann, SP; Hayward, C; Killen, DT; Killen, JD; Lowenthal, K; Murphy, GM; Schatzberg, AF | 1 |
| Bailey, SR; Bryson, SW; Killen, JD | 1 |
| Anthenelli, RM; Elkashef, A; Glover, ED; Gorgon, L; Jackson, T; Jones, K; Kahn, R; McSherry, F; Montoya, I; Murtaugh, C; Williams, J; Yu, E | 1 |
| George, TP; Termine, A; Vessicchio, JC | 1 |
| Houtsmuller, EJ; Stitzer, ML; Thornton, JA | 1 |
| George, TP; Jatlow, PI; Kosten, TR; O'Malley, SS; Termine, A; Vessicchio, JC | 1 |
| Biberman, R; Gerber, Y; Katzir, I; Neumann, R | 1 |
11 trial(s) available for selegiline and Smoking Cessation
| Article | Year |
|---|---|
Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Alleles; Chromosomes, Human, Pair 15; Craving; Double-Blind Method; Female; Genetic Markers; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Selegiline; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2015 |
A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.
Topics: Administration, Oral; Adolescent; Adult; Aged; Carbon Monoxide; Cotinine; Dizziness; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Monoamine Oxidase Inhibitors; Placebos; Selegiline; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Xerostomia; Young Adult | 2010 |
Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation.
Topics: Adult; Attitude to Health; Female; Follow-Up Studies; Health Behavior; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Motivation; Patient Acceptance of Health Care; Selegiline; Self Efficacy; Smoking; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2010 |
Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Behavior Therapy; Breath Tests; Carbon Monoxide; Female; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Monoamine Oxidase Inhibitors; Motivation; Recurrence; Regression Analysis; Selegiline; Sex Distribution; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2010 |
Differences in smoking expectancies in smokers with and without a history of major depression.
Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Selegiline; Sex Factors; Smoking; Smoking Cessation; Surveys and Questionnaires; Young Adult | 2011 |
Predicting successful 24-hr quit attempt in a smoking cessation intervention.
Topics: Adult; Behavior Therapy; Double-Blind Method; Female; Follow-Up Studies; Health Promotion; Humans; Logistic Models; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Self Report; Sex Factors; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Transdermal Patch; Treatment Outcome | 2011 |
Selegiline transdermal system (STS) as an aid for smoking cessation.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Selegiline; Smoking; Smoking Cessation | 2012 |
Smoking cessation and panic attacks: a report of 2 cases.
Topics: Double-Blind Method; Female; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Panic Disorder; Placebos; Risk Factors; Selective Serotonin Reuptake Inhibitors; Selegiline; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Effects of selegiline (L-deprenyl) during smoking and short-term abstinence.
Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Reaction Time; Regression Analysis; Selegiline; Smoking; Smoking Cessation | 2002 |
A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation.
Topics: Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Odds Ratio; Selegiline; Smoking; Smoking Cessation; Time Factors | 2003 |
A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Nicotine; Selegiline; Smoking Cessation | 2003 |
1 other study(ies) available for selegiline and Smoking Cessation
| Article | Year |
|---|---|
Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
Topics: Animals; Brain; Clorgyline; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Isoenzymes; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nicotine; Rats; Rats, Sprague-Dawley; Selegiline; Smoking Cessation; Substance Withdrawal Syndrome | 2013 |